News for 'Clinical Science'

Human trials of Covaxin set to begin at AIIMS, Odisha institute

Human trials of Covaxin set to begin at AIIMS, Odisha institute

Rediff.com20 Jul 2020

AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting Phase I and II randomised, double-blind and placebo-controlled clinical trials of Covaxin.

Govt seals deal for 30cr vaccines from Hyderabad firm

Govt seals deal for 30cr vaccines from Hyderabad firm

Rediff.com3 Jun 2021

The COVID-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials.

Criminal complaint against Ramdev for COVID-19 drug claim

Criminal complaint against Ramdev for COVID-19 drug claim

Rediff.com24 Jun 2020

The complaint seeking registration of a first information report on cheating, criminal conspiracy and other charges was filed in the court of Chief Judicial Magistrate Mukesh Kumar here on Tuesday by Tamanna Hashmi, who identifies himself as a social worker and is often in news for his numerous court complaints against politicians over various issues.

Record 68,584 Covid patients recover in 24 hrs: Govt

Record 68,584 Covid patients recover in 24 hrs: Govt

Rediff.com3 Sep 2020

'India has registered the highest recoveries in a single day. 68,584 COVID-19 patients have recovered and been discharged in the last 24 hours. 'This has led to a surge in the total number of recovered patients which is nearly 30 lakh (2,970,492). 'With this, India's Recovery Rate amongst the COVID-19 patients has crossed 77 per cent (77.09 per cent), the govt said.

The teen who could revolutionise the war against heart attacks

The teen who could revolutionise the war against heart attacks

Rediff.com28 Dec 2017

He invented a skin patch that can detect a silent heart attack 6 hours before it happens!

It's raining IPOs! 40-odd issues to mop up Rs 80K cr

It's raining IPOs! 40-odd issues to mop up Rs 80K cr

Rediff.com7 Jul 2021

The primary market is set for a bumper Rs 80,000-crore bonanza with 30 companies already filing IPO papers to raise Rs 55,000 crore, while around 10 more are lined up for this month itself, seeking to mop up another Rs 25,000 crore, say investment bankers. The market has been on a non-stop rally, hitting new records almost every week, on the back of an influx of investors -- a vast majority of them first-timers -- coupled with a flood of liquidity. Foreign funds alone had pumped in a record $35 billion into the market in FY21, while the trend has continued this fiscal as well. Domestic institutions led by LIC have also infused trillions of rupees, helping woo retail investors in troves -- the year saw over 20 million new investors coming to the market.

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Rediff.com11 Apr 2021

Remdesivir is considered a key anti-viral drug in the fight against Covid-19. In addition, the government has taken three steps to ensure easy access of hospitals and patients to Remdesivir.

Cadila launches Remdesivir in India at Rs 2,800 per vial

Cadila launches Remdesivir in India at Rs 2,800 per vial

Rediff.com13 Aug 2020

The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

Reporting of COVID cases post vaccination rare: Vardhan

Reporting of COVID cases post vaccination rare: Vardhan

Rediff.com30 Mar 2021

Vardhan noted that COVID-19 infection among those vaccinated would be very mild and not progress to an advanced stage.

Not yet clear if Omicron more transmissible: WHO

Not yet clear if Omicron more transmissible: WHO

Rediff.com29 Nov 2021

The World Health Organisation has said it is 'not yet clear' whether the newly-detected coronavirus variant Omicron is more transmissible or causes more severe disease compared to other variants, including the highly-transmissible and globally prevalent Delta variant.

Heart, BP patients likely to be infected with COVID-19 again: Study

Heart, BP patients likely to be infected with COVID-19 again: Study

Rediff.com24 Jun 2020

Researchers from Huazhong University of Science and Technology in China assessed data on 938 COVID-19 patients from the country's Wuhan Union Hospital. They obtained information about residual symptoms in these patients, and the results of follow up tests for viral genetic material in their body after they were discharged.

An Indian American in the White House?

An Indian American in the White House?

Rediff.com13 Mar 2023

What would an Indian American president of the US look like, sound like and act like, especially on issues and policies pertaining to his or her 'mother-land'?, asks N Sathiya Moorthy.

What I learnt from fighting COVID-19

What I learnt from fighting COVID-19

Rediff.com24 Aug 2020

'The genetic thing is not in your control. The virulence is not known.' 'The only thing is if you can avoid it.' 'Once you get COVID-19, none of it is in your control.'

Oxford vaccine doing 'everything expected': Study

Oxford vaccine doing 'everything expected': Study

Rediff.com22 Oct 2020

A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.

Johnson & Johnson says its Covid shot neutralises Delta variant

Johnson & Johnson says its Covid shot neutralises Delta variant

Rediff.com2 Jul 2021

In the ensemble trial, Johnson & Johnson's vaccine was 85 per cent effective against severe/critical disease and demonstrated protection against hospitalisation and death. The vaccine was consistently effective across all regions studied globally, including in South Africa and Brazil, where there was a high prevalence of rapidly emerging Beta and Zeta variants during the study period.

Mumbai student designs 'cool PPE kit' with ventilation for COVID warriors

Mumbai student designs 'cool PPE kit' with ventilation for COVID warriors

Rediff.com24 May 2021

This design serves two purposes -- first, keeps the health workers well-ventilated, while preventing bodily discomfort, and second, keeps them safe from various fungal infections.

Hijab Case: Why Muslim Liberals Will Lose

Hijab Case: Why Muslim Liberals Will Lose

Rediff.com17 Oct 2022

The educated, respectable and established Muslims voices, that were on the modernising side on the Shah Bano issue, are fighting on the opposite side now, mostly because they worry about Narendra Modi, observes Shekhar Gupta.

Never dreamed my research would take the direction it has: Nobel Medicine Prize winner Allison

Never dreamed my research would take the direction it has: Nobel Medicine Prize winner Allison

Rediff.com2 Oct 2018

He is the first MD Anderson scientist to receive the world's most preeminent award for outstanding discoveries in the fields of life sciences and medicine.

PIO entrepreneur to bring smart glasses to India

PIO entrepreneur to bring smart glasses to India

Rediff.com4 Mar 2019

OXSIGHT, founded in 2016 to create wearable technology devices based on how the brain manages visual information, began conducting trials in India two years ago in partnership with leading eye hospitals and clinics.

'COVID-19 vaccine will be made in India'

'COVID-19 vaccine will be made in India'

Rediff.com12 Jun 2020

'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'

23-yr-old becomes 1st COVID-19 case in Northeast

23-yr-old becomes 1st COVID-19 case in Northeast

Rediff.com24 Mar 2020

She had reached Delhi from London on March 18 and taken another flight to Kolkata, where she stayed for a few days with fever and a sore throat. From there she took a flight to Imphal via Agartala on March 21, official sources said.

PG Diploma at CREMA

PG Diploma at CREMA

Rediff.com16 Jan 2009

CREMA (Clinical Research Education and Management Academy) opens admissions for its one-year, part-time PG Diploma.

COVID-19 vaccine development at early stage in India: Experts

COVID-19 vaccine development at early stage in India: Experts

Rediff.com23 May 2020

The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

COVID-19 vaccine: 'You can't give false hope'

COVID-19 vaccine: 'You can't give false hope'

Rediff.com14 Jul 2020

'We are going ahead with the trials assuming what we have is the vaccine.' 'There is also a chance that what you have is not the vaccine. Then, you have to go back to the drawing board again.' 'So far, there has been no success in developing a good vaccine against coronaviruses.' 'That's why there are hundreds of trials going on at different stages in different parts of the world.'

Speedy distribution of vaccine major global challenge: WHO experts

Speedy distribution of vaccine major global challenge: WHO experts

Rediff.com5 Jan 2021

As India launches the world's most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines to secure immunity for its entire population, two prominent Indian scientists at World Health Organisation have said.

Test for TB if cough persists: Govt's revised Covid guidelines

Test for TB if cough persists: Govt's revised Covid guidelines

Rediff.com18 Jan 2022

Anti-inflammatory or immunomodulatory therapy, such as steroids, can have the risk of secondary infection like invasive mucormycosis, when used too early, at higher dose or for longer than required, they highlighted.

AIIMS chief warns against going for CT scan in mild COVID cases

AIIMS chief warns against going for CT scan in mild COVID cases

Rediff.com3 May 2021

"One CT scan is equivalent to 300 to 400 chest x-rays. According to data, repeated CT scans in younger age groups increase the risk of cancer in later life. Exposing yourself to radiation again and again may cause damage. So, there is no point in doing CT scan in mild COVID-19 if the oxygen saturation is normal," Guleria said.

No one safe until all vaccinated for Covid: Johns Hopkins scientist

No one safe until all vaccinated for Covid: Johns Hopkins scientist

Rediff.com22 Apr 2022

Vaccine inequity remains an issue in India, where less than 2 per cent of the population has received a Covid booster

Covaxin emergency use decision likely in 4-6 weeks: WHO

Covaxin emergency use decision likely in 4-6 weeks: WHO

Rediff.com10 Jul 2021

There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.

US lifts Covid curbs on fully-vaccinated travellers from Nov 8

US lifts Covid curbs on fully-vaccinated travellers from Nov 8

Rediff.com26 Oct 2021

The US will lift all restrictions for fully vaccinated international travellers, including from India, from November 8 but they will have to show proof of a negative coronavirus test before boarding a flight to the country, the White House has announced.

Can avocados help delay diabetes?

Can avocados help delay diabetes?

Rediff.com27 Nov 2019

Avocation B (AvoB), a fat molecule found only in avocados counters incomplete oxidation in skeletal muscle and the pancreas to reduce insulin resistance.

Broke no rule, obtained licence for COVID-19 drug: Patanjali

Broke no rule, obtained licence for COVID-19 drug: Patanjali

Rediff.com25 Jun 2020

"The licence for the drug was obtained on the basis of the traditional knowledge and experience related to the medicinal virtues of Ashwagandha, Giloy and Tulsi," Patanjali spokesperson S K Tijarawala said.

DRDO's 1st batch of anti-Covid drug 2DG launched

DRDO's 1st batch of anti-Covid drug 2DG launched

Rediff.com17 May 2021

The drug comes in powder form in a sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.

UK signs deal for 90 million COVID-19 vaccine doses

UK signs deal for 90 million COVID-19 vaccine doses

Rediff.com20 Jul 2020

To enable large-scale vaccine studies to take place across the UK, the aim is to get 500,000 people signed up by October, which is considered vital in the fight against coronavirus.

The maverick who changed India's legal education

The maverick who changed India's legal education

Rediff.com10 Feb 2020

Whenever the history of India's National Law Schools is written, N R Madhava Menon's name will be deeply inscribed in it, says Mohammad Zeeshan Ahmad.

Israel develops key Covid antibody that 'attacks and neutralises' virus

Israel develops key Covid antibody that 'attacks and neutralises' virus

Rediff.com5 May 2020

The statement said that the antibody's development had been completed and that the institute was in the process of patenting the find 'and in the next stage, researchers will approach international companies to produce the antibody on a commercial scale'.

Why Covid Cases Are Rising

Why Covid Cases Are Rising

Rediff.com8 Jun 2022

'Since many people are vaccinated, this virus is now concentrating on the throat and the nose and replicating fast and transmitting also very fast.' 'That's because the current vaccines will not be able to fight it when it is in the throat, nose or the mouth.'

India's COVID-19 figures worrying: WHO chief scientist

India's COVID-19 figures worrying: WHO chief scientist

Rediff.com11 May 2021

Soumya Swaminathan called on governments to boost exercises on reporting actual numbers.

Govt developing multi-variant Covid-19 vaccine

Govt developing multi-variant Covid-19 vaccine

Rediff.com14 Sep 2021

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus, reports Sohini Das.